Detection of Minimal Residual Disease in a Patient Having Acute Myelogenous Leukemia with t(16;21)(p11;q22) Treated by Allogeneic Bone Marrow Transplantation

Publisher： Karger

E-ISSN： 1421-9662|105|1|45-48

ISSN： 0001-5792

Source： Acta Haematologica, Vol.105, Iss.1, 2001-04, pp. : 45-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

A der(1)t(1;21)(p36.3;q22) in a Patient with Acute Myelogenous Leukemia M2

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 44-45

Karger

Access to resources Recommend Favorite

Long‐term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12)

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 312-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1493-1500

John Wiley & Sons Inc

Access to resources Recommend Favorite

t(16;21)(q24;q22) in Acute Myeloid Leukemia: Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 119, Iss. 2, 2008-02 ,pp. : 65-68

Karger

Access to resources Recommend Favorite